The Food Safety and Standards Authority of India (FSSAI) has initiated legal action against Nestle India, demanding clarifications on claims related to ‘5HMOs’ and ‘Whey Protein’ in its infant nutrition products. This move, first reported by The Hindu, increases the regulator’s scrutiny of labelling practices and health claims. This scrutiny extends beyond large corporations to directly impact India’s clean-label D2C food brands.

This action against Nestle arrives amidst what Inc42 describes as India’s largest food-regulation crackdown in years, particularly targeting the “clean label” segment. For months, the FSSAI has been intensifying its oversight of product claims, a trend our publication noted on August 9, 2026, in an article titled “FSSAI Intensifies Labelling Scrutiny as Courts Demand Due Process.” Courts were already demanding clearer processes from the FSSAI regarding its regulatory actions at that time. Just five days later, on August 14, 2026, the Supreme Court itself questioned the FSSAI’s stance, as reported by StartupTalky. This shows the judicial branch’s active role in shaping food regulation.

The current legal challenge against Nestle India, a major player, shows the FSSAI is enforcing rules across all company sizes. While the specific nature of the claims – ‘5HMOs’ and ‘Whey Protein’ – relates to infant nutrition, the broader implications for any company making specific ingredient or health benefit assertions on packaging are immediate. This puts the “Clean Label Credibility Test” on D2C startups that have built their brands on promises of natural ingredients, specific nutritional profiles, or the absence of artificial additives.

Implications for Indian Startups in Food and D2C

For Indian startups, especially those in the direct-to-consumer food sector, this changing regulatory environment demands immediate attention. Many D2C food brands differentiate themselves by highlighting specific ingredients, sourcing practices, or health benefits on their packaging and marketing materials. The FSSAI’s actions suggest that vague or unsubstantiated claims, even those perceived as minor, will face heightened scrutiny.

  • Review Labelling and Claims: Startups must conduct a thorough audit of all product labels, marketing collateral, and website content. Every claim, especially those related to “clean,” “natural,” “healthy,” or specific ingredient benefits like protein content or the presence of complex molecules, should be backed by verifiable scientific data or regulatory definitions. The FSSAI’s request for clarifications from Nestle on ‘5HMOs’ and ‘Whey Protein’ shows a detailed focus on the scientific basis of such assertions.
  • Understand Regulatory Definitions: The term “clean label” itself lacks a universal regulatory definition. Startups relying on this moniker must ensure their interpretation aligns with existing FSSAI guidelines for ingredients, additives, and processing, or be prepared to scientifically defend their specific claims. The ongoing “Clean Label Credibility Test” mentioned by Inc42 shows that using the term without rigorous adherence to food safety and ingredient transparency standards creates a significant business risk.
  • Prepare for Judicial Scrutiny: With the Supreme Court already weighing in on FSSAI’s methods, startups must anticipate that regulatory challenges could escalate to judicial review. Ensuring internal compliance processes are strong and documented, and that all claims are defensible, is now a requirement. This is particularly relevant for new product development, where innovative ingredients or formulations might push the boundaries of existing regulations.

What is the FSSAI’s current focus in food regulation?

The FSSAI is currently focused on intensifying scrutiny of product labelling and health claims, particularly targeting “clean label” brands and specific ingredient assertions like ‘5HMOs’ and ‘Whey Protein’.

Nestle India is facing legal action from the FSSAI, which has sought clarifications on claims related to ‘5HMOs’ and ‘Whey Protein’ in its infant nutrition products.

What role have courts played in FSSAI’s regulatory actions?

The Supreme Court questioned the FSSAI’s stand on August 14, 2026, reinforcing a pattern where courts are demanding due process in the regulator’s handling of labelling scrutiny.

Compiled by Launch91 Desk from the sources linked above. More about Launch91.